Literature DB >> 3382141

Intrathecal baclofen for severe spasticity.

R D Penn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3382141     DOI： 10.1111/j.1749-6632.1988.tb31822.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  15 in total

1.  Virtual electric power wheelchair driving performance of individuals with spastic cerebral palsy.

Authors:  Brad E Dicianno; Harshal Mahajan; Alcinto S Guirand; Rory A Cooper
Journal:  Am J Phys Med Rehabil       Date:  2012-10       Impact factor: 2.159

2.  Management of intrathecal baclofen therapy for severe acquired brain injury: consensus and recommendations for good clinical practice.

Authors:  Antonio De Tanti; Federico Scarponi; Michele Bertoni; Giulio Gasperini; Bernardo Lanzillo; Franco Molteni; Federico Posteraro; Dino Francesco Vitale; Mauro Zanpolini
Journal:  Neurol Sci       Date:  2017-05-06       Impact factor: 3.307

3.  Comparison of the effects of body-weight-supported treadmill training and tilt-table standing on spasticity in individuals with chronic spinal cord injury.

Authors:  Melanie M Adams; Audrey L Hicks
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

4.  Energy expenditure after spinal cord injury in people with motor-complete tetraplegia or motor-complete paraplegia.

Authors:  Tobias Holmlund; Elin Ekblom-Bak; Erika Franzén; Claes Hultling; Kerstin Wahman
Journal:  Spinal Cord       Date:  2017-12-14       Impact factor: 2.772

5.  Energy expenditure in people with motor-complete paraplegia.

Authors:  T Holmlund; E Ekblom-Bak; E Franzén; C Hultling; L Nilsson Wikmar; K Wahman
Journal:  Spinal Cord       Date:  2017-04-04       Impact factor: 2.772

6.  Extensor spasms triggered by imposed knee extension in chronic human spinal cord injury.

Authors:  Ming Wu; T George Hornby; Jennifer Hilb; Brian D Schmit
Journal:  Exp Brain Res       Date:  2004-12-07       Impact factor: 1.972

7.  Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin.

Authors:  A Zahavi; J H B Geertzen; B Middel; M Staal; J S Rietman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

8.  Intraspinal baclofen in the treatment of severe spasticity and spasms.

Authors:  J Sahuquillo; T Muxi; M Noguer; R Jodar; C Closa; E Rubio; L Garcia-Fernandez; J M Guitart
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

9.  Development and validation of Patient Reported Impact of Spasticity Measure (PRISM).

Authors:  Karon F Cook; Cayla R Teal; Joan C Engebretson; Karen A Hart; Jane S Mahoney; Susan Robinson-Whelen; Arthur M Sherwood
Journal:  J Rehabil Res Dev       Date:  2007

10.  Altered patterns of reflex excitability, balance, and locomotion following spinal cord injury and locomotor training.

Authors:  Prodip K Bose; Jiamei Hou; Ronald Parmer; Paul J Reier; Floyd J Thompson
Journal:  Front Physiol       Date:  2012-07-18       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.